The earnings call highlights DarioHealth's strong client acquisition, improved gross margins, and strategic partnerships, indicating a solid foundation for future growth. However, the revenue decline, delayed cash flow breakeven, and loss of a significant contract present notable challenges. Despite these setbacks, the company's strategic focus on AI and operational efficiency provides a positive outlook for recovery and growth.

Company Guidance -

Q3 2025

During the DarioHealth Second Quarter 2025 Results Conference Call, the company provided guidance highlighting several key metrics and operational insights. The company reported a revenue decline to $5.4 million from $6.3 million year-over-year, attributing this to the nonrenewal of a large national health plan and a strategic shift toward a SaaS-like recurring revenue model. Despite these short-term challenges, DarioHealth has secured $5 million in newly committed annual recurring revenues (CARR) and has a robust pipeline of $53 million, with $5 million in final stages towards CARR. The company aims to reach cash flow breakeven by the end of 2026 to the beginning of 2027, adjusting its previous estimate by 12 to 15 months. Gross margin increased to 55% year-over-year, with the B2B2C segment maintaining over 80% gross margins on a non-GAAP basis. Operating expenses were reduced by 36%, leading to a 43% decrease in operating loss. The company is optimistic about future growth, having signed 21 new clients year-to-date, with 80% focused on multi-condition programs. DarioHealth also emphasized the importance of AI in enhancing operational efficiency and customer engagement, projecting a 15% reduction in operating expenses over the next 12 to 15 months.

Strong Client Acquisition and Pipeline Growth

DarioHealth has signed 21 new clients year-to-date, with 80% for multi-condition programs. The pipeline has grown to $53 million, with $5 million in committed annual recurring revenues (CARR) and additional $5 million in late-stage contracting.

Improved Gross Margins and Reduced Operating Expenses

GAAP gross margin increased to 55% from 44% year-over-year. Operating expenses were reduced by 36%, and operating loss was narrowed by 43% year-over-year.

High Retention Rates and Diversified Client Base

DarioHealth reported an 85% client retention rate and has over 100 clients, including health plans, self-insured employers, and pharmaceutical partners.

Strategic Partnerships and Market Expansion

Partnerships with benefit consultants and channel partners like Amwell and Solera have increased access to target employer markets and opened new business opportunities.

AI Integration and Operational Efficiency

DarioHealth is leveraging AI to streamline operations and reduce operating expenses, aiming for a 15% reduction in OpEx over the next 12 to 15 months.

DarioHealth (DRIO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DRIO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 17, 2025	2025 (Q3)	-0.24 / -	-0.25	―	―	―
Aug 12, 2025	2025 (Q2)	-0.23 / -0.18	-0.08	-125.00% (-0.10)	―
May 14, 2025	2025 (Q1)	-0.10 / -0.14	-0.2	30.00% (+0.06)	―
Mar 10, 2025	2024 (Q4)	-0.33 / -0.08	-0.41	80.49% (+0.33)	―
Nov 07, 2024	2024 (Q3)	-0.22 / -0.25	-0.49	48.98% (+0.24)	―
Aug 08, 2024	2024 (Q2)	-0.45 / -0.08	-0.58	86.21% (+0.50)	―
May 15, 2024	2024 (Q1)	-0.29 / -0.20	-0.45	55.56% (+0.25)	―
Mar 28, 2024	2023 (Q4)	-0.39 / -0.41	-0.42	2.38% (+0.01)	―
Nov 02, 2023	2023 (Q3)	-0.52 / -0.49	-0.64	23.44% (+0.15)	―
Aug 10, 2023	2023 (Q2)	-0.51 / -0.58	-0.74	21.62% (+0.16)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DRIO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 12, 2025	$0.50	$0.43	-14.00%
May 14, 2025	$0.72	$0.66	-8.33%
Mar 10, 2025	$0.73	$0.67	-8.22%
Nov 07, 2024	$0.96	$0.97	+1.04%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does DarioHealth Corp (DRIO) report earnings?

DarioHealth Corp (DRIO) is schdueled to report earning on Nov 17, 2025, Before Open (Confirmed).

What is DarioHealth Corp (DRIO) earnings time?

DarioHealth Corp (DRIO) earnings time is at Nov 17, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is DRIO EPS forecast?

DRIO EPS forecast for the fiscal quarter 2025 (Q3) is -0.24.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing